Measurable residual disease negativity in acute myeloid leukemia: The destination may matter more than the journey Editorial

  

Authors:	Stahl, M.; Tallman, M. S.; Goldberg, A. D.
Title:	Measurable residual disease negativity in acute myeloid leukemia: The destination may matter more than the journey
Keywords:	gene mutation; overall survival; allogeneic stem cell transplantation; salvage therapy; note; disease free survival; flow cytometry; recurrence risk; disease association; cytogenetics; minimal residual disease; age distribution; leukemia relapse; induction chemotherapy; leukemia remission; clinical outcome; acute myeloid leukemia; human; venetoclax; diagnosis time
Journal Title:	Leukemia and Lymphoma
Volume:	62
Issue:	9
ISSN:	1042-8194
Publisher:	Taylor & Francis Group
Date Published:	2021-09-01
Start Page:	2050
End Page:	2051
Language:	English
DOI:	10.1080/10428194.2021.1929967
PROVIDER:	scopus
PUBMED:	34519611
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85115087570&doi=10.1080%2f10428194.2021.1929967&partnerID=40&md5=277781e01ab80df8ebb6b5be822e575b
Notes:	Correction to publication issue, DOI: 10.1080/10428194.2021.1979293 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/188943